Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PSC 833 + Paclitaxel in Metastatic Breast Cancer
NCT00002826Phase 2Completed
- Sponsor
- Eastern Cooperative Oncology Group
- Start
- Aug 1997
- Primary completion
- Nov 2003
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of valspodar in breast cancer, sponsored by Eastern Cooperative Oncology Group. Started Aug 1997; status: completed.
02
Drugs
valspodar
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00002826.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00002826.